SOLICITATION NOTICE
B -- IDIQ Electrophysiological and Contractility Assessment of Drugs on Primary Adult Ventricular Tissues
- Notice Date
- 8/13/2019
- Notice Type
- Combine Synopsis/Solicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- 4041 Powder Mill Road Beltsville MD 20705
- ZIP Code
- 20705
- Solicitation Number
- FDA-19-RFQ-1212228
- Response Due
- 8/23/2019
- Point of Contact
- Christopher R. McGucken, Contract Specialist, Phone (240) 402-7566
- E-Mail Address
-
christopher.mcgucken@fda.hhs.gov
- Small Business Set-Aside
- N/A
- Description
- The U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER), Division of Applied Regulatory Science has a requirement to obtain electrophysiology and contractility data using adult primary human ventricular tissues from healthy donors for a number of drugs that perturb cardiac functions based on clinical data. Outcomes of this contract will enable better understanding of the cellular mechanisms of drug-induced cardiotoxicity. This contract is thus consistent with the FDA's mission of protecting public health by ensuring the safety and efficacy of drugs available to the American public. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (13-AUG-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-19-RFQ-1212228/listing.html)
- Record
- SN05403438-F 20190815/190813230041 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |